Ece Erbağcı

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

End Stage Renal Disease

Atopic Dermatitis

Ejection Fraction

Top Venues

Journal of cosmetic dermatology

The Australasian journal of dermatology

Journal of cutaneous pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Ece Erbağcı, Sema Koç Yıldırım, Fatma Aslı Hapa
Evaluation of serial QuantiFERON-TB Gold in tube test results and tuberculosis infection status in patients with psoriasis receiving anti-IL-17 treatment (secukinumab and ixekizumab): Real-world data from a tuberculosis-endemic country. The Australasian journal of dermatology (2024)
Sema Koç Yıldırım, Ece Erbağcı, Aslı Hapa
Omalizumab treatment in combination with any other biologics: Is it really a safe duo? The Australasian journal of dermatology (2023)
Sema Koç Yıldırım, Ece Erbağcı, Neslihan Demirel Öğüt
Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium? Journal of cosmetic dermatology 21 (5) (2022)
Sema Koç Yıldırım, Neslihan Demirel Öğüt, Ece Erbağcı
Retrospective evaluation of patients with chronic spontaneous urticaria using omalizumab during the COVID-19 pandemic. Journal of cosmetic dermatology 21 (2) (2022)
Ece Erbağcı, Ayşen Karaduman, Özay Gököz, Sibel Ersoy Evans
Merkel cell number and distribution, and CD200 expression in patients with lichen planopilaris and discoid lupus erythematosus. Journal of cutaneous pathology 49 (12) (2022)
Ece Erbağcı, Neslihan Demirel Öğüt, Sema Koç Yıldırım, Fatma Aslı Hapa
Is dupilumab effective in adult-onset atopic dermatitis: Real-life experience of 16 patients. Journal of cosmetic dermatology 21 (10) (2022)